Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sarepta Therapeutics gets stop work order from US defense dept
Reuters
Saturday, August 4, 2012 - 11:24am
tags:
Sarepta, ebola virus
Momenta Loses In Appeals Court Over Watson’s Lovenox Copy
Bloomberg
Saturday, August 4, 2012 - 11:23am
tags:
Momenta, Lovenox, Watson, generics, lawsuits
Medivation and Astellas Announce PDUFA Action Date for Enzalutamide NDA
Yahoo/MarketWire
Saturday, August 4, 2012 - 11:22am
tags:
Medivation, Astellas, Enzalutamide, prostate cancer
Bad News for ViroPharma
Yahoo/Zacks
Saturday, August 4, 2012 - 11:20am
tags:
ViroPharma, Halozyme, Cinryze, rHuPH20
Hyperion Therapeutics: One Stock I'm Adding Post-IPO
Seeking Alpha
Saturday, August 4, 2012 - 11:18am
tags:
Hyperion Therapeutics
ImmunoGen slips after forecasting bigger loss
Yahoo/AP
Saturday, August 4, 2012 - 11:17am
tags:
Immunogen
Momenta Pharmaceuticals Acknowledges Federal Circuit Opinion Supporting Order Issued January 26, 2012 in Ongoing Suit Against Amphastar Pharmaceuticals and Watson Pharmaceuticals
Yahoo/GlobeNewsWire
Saturday, August 4, 2012 - 11:16am
tags:
Momenta, Amphastar, lawsuits
Biotech Investors: We Don't Do Math
Motley Fool
Saturday, August 4, 2012 - 11:15am
tags:
Amgen Inc (AMGN): Today's Featured Health Care Winner
The Steet
Saturday, August 4, 2012 - 11:13am
tags:
Amgen
Arena Pharmaceuticals Inc.: Today's Featured Drugs Laggardq
The Steet
Saturday, August 4, 2012 - 11:12am
tags:
Arena Pharmaceuticals
Stem Cell Therapy Space Worth Review for Investors
Motley Fool
Friday, August 3, 2012 - 2:26pm
tags:
stem cells, Baxter, Osiris, MiMedx
FDA approves Sanofi/Regeneron colon cancer drug
Reuters
Friday, August 3, 2012 - 2:24pm
tags:
FDA, Sanofi, Regeneron, colon cancer, Zaltrap
VIVUS Second Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Friday, August 3, 2012 - 11:55am
tags:
Vivus, earnings
Arena Pharmaceuticals Second Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Friday, August 3, 2012 - 11:44am
tags:
Arena, earnings
Johnson & Johnson releases some Doxil for trials
Fierce Pharma
Friday, August 3, 2012 - 11:32am
tags:
Doxil, JNJ, cancer, clinical trials, Boehringer Ingelheim, Endocyte
Sanofi, Otsuka amp up their Turkish ambitions
Fierce Pharma
Friday, August 3, 2012 - 11:29am
tags:
Otsuka, Sanofi, Turkey
Clovis Oncology ovarian cancer treatment receives orphan status
Yahoo/Fly on the Wall
Friday, August 3, 2012 - 11:26am
tags:
ovarian cancer, orphan drugs, Clovis Oncology
[video] The Next Big Thing in Biotech: FDA Approvals
TheStreet.com
Friday, August 3, 2012 - 11:25am
tags:
FDA, Amarin, Vivus, Arena, drug approvals
GSK completes $3 billion acquisition of Human Genome
Reuters
Friday, August 3, 2012 - 11:23am
tags:
GSK, Human Genome Sciences, M&A
Glaxo Files Two Melanoma Drugs For U.S., Europe Approvals
Bloomberg
Friday, August 3, 2012 - 11:23am
tags:
melanoma, GSK, trametinib, dabrafenib

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.